The Weston Brain Institute is pleased to launch the Early Phase Clinical Trials: Canada program.
This opportunity provides funding for clinical trials and clinical trial sub-studies that accelerate the development of therapeutics for neurodegenerative diseases of aging
The Early Phase Clinical Trials program was created to provide significant support for clinical trials and/or clinical trial sub-studies that have excellent preliminary data.
The Institute has updated which tools are in scope. Please read What We Fund before applying to ensure your project is in scope
The Early Phase Clinical Trials: Canada program will be run on a rolling basis
Institute definition of neurodegenerative diseases of aging:
- Alzheimer’s disease
- Dementia with Lewy bodies
- Frontotemporal dementia
- Multiple system atrophy
- Parkinson’s disease
- Progressive supranuclear palsy
- Vascular contributions to the above diseases
- Prodromes to the above diseases
For more information, please visit our website.